Skip to content
ClinCalc Pro
Menu
gi-hepatology

Rome IV Diagnostic Criteria for Cyclic Vomiting Syndrome (CVS)

Rome IV criteria for Cyclic Vomiting Syndrome in adults. Stereotypical recurrent episodes of intense nausea and vomiting with intervening symptom-free periods. Associated with migraine spectrum disorders.

Used in: Headache & Migraine

Score interpretation

CVS Criteria NOT Met 0–3

Insufficient criteria for CVS -- investigate for structural or metabolic causes

→ Exclude organic causes: upper endoscopy; CT abdomen/pelvis; metabolic screen (thyroid, adrenal, porphyria); CNS imaging if neurological symptoms; gastric emptying study for gastroparesis; SMA syndrome. Consider cannabinoid hyperemesis syndrome (cannabis use + hot showers relief = highly suggestive).

Cyclic Vomiting Syndrome Criteria Met 4

Rome IV CVS confirmed -- acute and prophylactic management required

→ Acute episode: IV fluids (aggressive hydration); IV ondansetron 4-8 mg 6-hourly; IV lorazepam 0.02-0.05 mg/kg (for intractable nausea, reduces vomiting); IV haloperidol 0.5-2 mg (emerging evidence -- D2 antagonist, useful for refractory CVS); IV diphenhydramine 25 mg; electrolyte replacement; dark quiet room; IV sumatriptan (6 mg SC) if migraine-CVS variant; Prophylaxis: tricyclic antidepressants (amitriptyline 10-75 mg nocte -- first-line); coenzyme Q10 30 mg TDS; L-carnitine 1 g TDS (mitochondrial support); topiramate 25-100 mg BD; propranolol 10-20 mg TDS; if cannabis-related: complete cessation (cannabinoid hyperemesis -- hot shower compulsive bathing pathognomonic); capsaicin cream topical (evidence emerging for CHS); psychiatric assessment (anxiety, depression, OCD common); gastroenterology follow-up.

Interpretation bands for the Rome IV CVS. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.